Entering terms or keywords in the Data Dictionary search above provides a definition, and entering specific terms within the data archive provides data location.
| Term | Definition | Code | Phase | Table | CRF |
|---|---|---|---|---|---|
| PTID | Participant ID | -4 | ADNI1 | ADNIMERGE | Key ADNI tables merged into one table |
| BNP | Brain Natriuretic Peptide | -4 | ADNI1 | RBMQC | Rules Based Medicine Plasma Multiplex QC Data |
| CPEPTIDE | C-peptide | -4 | ADNI1 | RBMQC | Rules Based Medicine Plasma Multiplex QC Data |
| GLP1TO | Glucagon-like Peptide 1- total | -4 | ADNI1 | RBMQC | Rules Based Medicine Plasma Multiplex QC Data |
| PPP | Pancreatic Polypeptide | -4 | ADNI1 | RBMQC | Rules Based Medicine Plasma Multiplex QC Data |
| PYY | Peptide YY | -4 | ADNI1 | RBMQC | Rules Based Medicine Plasma Multiplex QC Data |
| PTID | Participant ID | N/A | ADNI1,ADNIGO,ADNI2,ADNI3 | ROSTER | Roster |
| HYDROXYPROLINE.DIPEPTIDE.NIST | -4 | -4 | N/A | ADMCGCTOF | ADMC Metabolomic Analysis by Gas chromatography time of flight mass spectrometry (GCTOF) Data [ADNI1] |
| PEAK_AREA_ABETA38_N14_B07 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A38 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA38_N14_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A38 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA38_N14_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A38 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA38_N15_B07 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A38 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA38_N15_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A38 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA38_N15_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A38 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B05 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B07 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B10 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_B11 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N14_TOUSE | Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A40 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B05 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b5 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B07 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b7 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B10 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_B11 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA40_N15_TOUSE | Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A40 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B10 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B11 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B12 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_B13 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N14_TOUSE | Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to endogenous A42 | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B08 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b8 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B09 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b9 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B10 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b10 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B11 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b11 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B12 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b12 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_B13 | Integrated Peak Area for chromatograms derived from MS/MS transition ion b13 for the LysN C-terminal peptide from 15N labled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| PEAK_AREA_ABETA42_N15_TOUSE | Summed intergrated peak Area across all quantitative MS/MS transitions for peptide specific to 15N labeled A42 internal standard | N/A | N/A | BATEMANLAB | Bateman Lab Plasma Abeta42/Abeta40 Ratio as a Predictor of Brain Amyloidosis |
| AMD_IPVDEEAFVIDFKPR | Peptidyl-glycine alpha-amidating monooxygenase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| AMD_IVQFSPSGK | Peptidyl-glycine alpha-amidating monooxygenase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| AMD_NGQWTLIGR | Peptidyl-glycine alpha-amidating monooxygenase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| CNDP1_ALEQDLPVNIK | Beta-Ala-His dipeptidase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| CNDP1_VFQYIDLHQDEFVQTLK | Beta-Ala-His dipeptidase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| CNDP1_WNYIEGTK | Beta-Ala-His dipeptidase | -4 | N/A | CSFMRM | Biomarkers Consortium CSF Proteomics MRM data set |
| PEPTIDE | Targeted peptide sequence | N/A | N/A | EMORY_PEPTIDERATIOS | Emory University CSF Targeted MS |
| TOTAL_AREA_RATIO | Light/Heavy peptide ratio | N/A | N/A | EMORY_PEPTIDERATIOS | Emory University CSF Targeted MS |
| ABETA40 | Amyloid peptide beta (x-40) | -4 | N/A | MESOSCALE | Meso Scale Diagnostics Analysis of Residual CSF Samples |
| ABETA42 | Amyloid beta peptide (x-42) | -4 | N/A | MESOSCALE | Meso Scale Diagnostics Analysis of Residual CSF Samples |
| PTID | Participant ID | N/A | N/A | NYUFDGHIP | NYU FDG-PET Hippocampus (pons normalized) |
| PLASMAAB4240 | Concentration ratio of 42/40 as measured by Di-oxidized C-terminal peptides, based on its relation to respective known concentrations of N15 internal standard | -4 | N/A | PLASMA_ABETA_PROJECT_WASH_U | FNIH Biomarkers Consortium Plasma Abeta Project: Wash U |
| PTAU_181 | Calibrated plasma phospho-tau 181 concentration in pg/mL (related to the peptide used as calibrator and not the full-length phosphorylated tau protein) | N/A | N/A | FNIH_PLASMA_PTAU181_PROJECT | FNIH Biomarkers Consortium Plasma pTau-181 Project |
| PTID | Subject Identifier | N/A | N/A | UCSFASLQC | ASL Perfusion Raw QC |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_ADL | Brain Health Registry SP ADL |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_CAREGIVER_BURDEN | Brain Health Registry SP CAREGIVER BURDEN |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_EVERYDAY_COGNITION | Brain Health Registry SP EVERYDAY COGNITION |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_FAQ | Brain Health Registry SP FAQ |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_INITIAL | Brain Health Registry SP INITIAL |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_RELATIONSHIP | Brain Health Registry SP RELATIONSHIP |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | BHR_SP_STUDY_CONFIRMATION | Brain Health Registry SP STUDY CONFIRMATION |
| AboutPTID | Code obtained from CBB CRF report of subject about whom the study partner provided responses | N/A | N/A | SP_INITIAL | CogState Brief Battery Report |
| PTID | Subject code obtained from the CogState Brief Battery CRF report | N/A | N/A | BHR_BASELINE_QUESTIONNAIRE | Brain Health Registry BASELINE QUESTIONNAIRE |
| PTID | Subject code obtained from the CogState Brief Battery CRF report | N/A | N/A | BHR_EVERYDAY_COGNITION | Brain Health Registry EVERYDAY COGNITION |
| PTID | Subject code obtained from the CogState Brief Battery CRF report | N/A | N/A | BHR_LONGITUDINAL_QUESTIONNAIRE | Brain Health Registry LONGITUDINAL QUESTIONNAIRE |
| PTID | Subject code obtained from the CogState Brief Battery CRF report | N/A | N/A | BHR_MEMTRAX | Brain Health Registry MEMTRAX |
| PTID | Subject Identifier | N/A | N/A | MAYOADIRL_MRI_ADNI3 | Jack Lab - ADNI GO/2/3 MRI QC |
| PTID | ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID" | N/A | N/A | UCBERKELEY_AMY_6MM | UC Berkeley - Amyloid PET 6mm Res analysis |
| PTID | ADNI Participant ID consisting of 3-digit "SITEID" and 4-digit "RID" | N/A | N/A | UCBERKELEY_TAU_6MM | UC Berkeley - Tau PET 6mm Res analysis |
